FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Dihydroergotamine Mesylate Injection
Status: Currently in Shortage
»Date first posted: 07/14/2016
»Therapeutic Categories: Neurology

Expand all

Perrigo Pharmaceuticals (Revised 06/21/2017)

Company Contact Information:
269-673-8451

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1mg/mL, 1mL ampul, 5 Unit Dose (NDC 0574-0850-05) Available Other
1mg/mL, 1mL ampul, 10 Unit Dose (NDC 0574-0850-10) Available Other

Valeant Pharmaceuticals North America LLC (Revised 07/10/2017)

Company Contact Information:
800-321-4576

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/mL, 1 mL ampule, package of 10 (NDC 66490-041-01) Product available Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English